Cargando…
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin
Background: Head and neck squamous cell carcinomas are the sixth most common malignant tumors worldwide. Tongue squamous cell carcinoma is a common malignant tumor of this type, and it is associated with poor prognosis, a high rate of recurrence and a low survival rate. Plumbagin is derived from Plu...
Autores principales: | Xin, Yuqi, Jiang, Qingkun, Liu, Chenshu, Qiu, Jiaxuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683608/ https://www.ncbi.nlm.nih.gov/pubmed/37925175 http://dx.doi.org/10.18632/aging.205175 |
Ejemplares similares
-
Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
por: Xue, Danfeng, et al.
Publicado: (2020) -
Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma
por: Xin, Yuqi, et al.
Publicado: (2020) -
lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway
por: Jiang, Qingkun, et al.
Publicado: (2021) -
Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches
por: Jamal, Mohammad S., et al.
Publicado: (2014) -
The enhanced genomic 6 mA metabolism contributes to the proliferation and migration of TSCC cells
por: Xi, Lei, et al.
Publicado: (2022)